Literature DB >> 17982165

Tophaceous joint disease strongly predicts hand function in patients with gout.

N Dalbeth1, J Collis, K Gregory, B Clark, E Robinson, F M McQueen.   

Abstract

OBJECTIVES: The functional impact of gout is poorly understood. The aim of this study was to determine predictors of hand function in gout.
METHODS: Twenty unselected patients with gout were recruited from rheumatology clinics. No patient had an acute gout flare at assessment. Participants were assessed for clinical characteristics of gout, including the site and number of tophi. Hand function was assessed by the Sollerman hand function test. Fingertip to palm (FTP) distance measurement, grip strength and the Disability Assessment of Shoulder and Hand (DASH) questionnaire scores were also recorded. Data were analysed by simple and multiple linear regression models.
RESULTS: The median Sollerman score was 75.5 (range 31-80). The median hand FTP distance was 2.91 (0.88-6.69) cm, grip strength was 31 (4-71) kg, and DASH score was 28.77 (0-76.47). Of the clinical characteristics measured, the number of joints of the hand with overlying tophi (hand tophus joint count) was the strongest single predictor of the Sollerman score (r2 = 0.59), and also predicted the other measures of hand mobility and function. A multiple regression model including hand tophus joint count, sex, number of gout flares in the preceding 6 months, gout disease duration and hand tender joint count was a better predictor of the Sollerman score than hand tophus joint count alone (r2 = 0.81, F(4,14) = 3.94, P = 0.024).
CONCLUSIONS: Measures of chronic and poorly controlled disease predict hand function in patients with gout. In particular, tophaceous joint disease has a major impact on functional capacity in gout.

Entities:  

Mesh:

Year:  2007        PMID: 17982165     DOI: 10.1093/rheumatology/kem246

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  30 in total

1.  Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology?

Authors:  Lisa K Stamp; Puja P Khanna; Nicola Dalbeth; Maarten Boers; Walter P Maksymowych; H Ralph Schumacher; Michael A Becker; Patricia A MacDonald; N Lawrence Edwards; Jasvinder A Singh; Lee S Simon; Fiona M McQueen; Tuhina Neogi; Angelo L Gaffo; Vibeke Strand; William J Taylor
Journal:  J Rheumatol       Date:  2011-07       Impact factor: 4.666

2.  Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities.

Authors:  Nicola Dalbeth; Fiona M McQueen; Jasvinder A Singh; Patricia A MacDonald; N Lawrence Edwards; H Ralph Schumacher; Lee S Simon; Lisa K Stamp; Tuhina Neogi; Angelo L Gaffo; Puja P Khanna; Michael A Becker; William J Taylor
Journal:  J Rheumatol       Date:  2011-07       Impact factor: 4.666

Review 3.  Urate-lowering therapy: current options and future prospects for elderly patients with gout.

Authors:  Lisa K Stamp; Peter T Chapman
Journal:  Drugs Aging       Date:  2014-11       Impact factor: 3.923

Review 4.  Impaired response or insufficient dosage? Examining the potential causes of "inadequate response" to allopurinol in the treatment of gout.

Authors:  Lisa K Stamp; Tony R Merriman; Murray L Barclay; Jasvinder A Singh; Rebecca L Roberts; Daniel F B Wright; Nicola Dalbeth
Journal:  Semin Arthritis Rheum       Date:  2014-05-09       Impact factor: 5.532

Review 5.  [Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh)].

Authors:  U Kiltz; R Alten; M Fleck; K Krüger; B Manger; U Müller-Ladner; H Nüßlein; M Reuss-Borst; A Schwarting; H Schulze-Koops; A Tausche; J Braun
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

6.  Gadolinium-enhanced MRI features of acute gouty arthritis on top of chronic gouty involvement in different joints.

Authors:  Yasser Emad; Yasser Ragab; Ahmed El-Naggar; Nashwa El-Shaarawy; Mayada A Abd-Allah; Rania M Gamal; Ahmed Fathy; Mona Hawass; Johannes J Rasker
Journal:  Clin Rheumatol       Date:  2015-02-14       Impact factor: 2.980

7.  Digital tomosynthesis as a new diagnostic tool for assessing of chronic gout arthritic feet and ankles: comparison of plain radiography and computed tomography.

Authors:  Chang-Nam Son; Yoonah Song; Sang-Hyon Kim; Seunghun Lee; Jae-Bum Jun
Journal:  Clin Rheumatol       Date:  2017-06-08       Impact factor: 2.980

Review 8.  Hyperuricaemia with deposition: latest evidence and therapeutic approach.

Authors:  Fernando Perez-Ruiz; Estibaliz Marimon; Sandra P Chinchilla
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-12       Impact factor: 5.346

Review 9.  Imaging of gout: findings and utility.

Authors:  Fernando Perez-Ruiz; Nicola Dalbeth; Aranzazu Urresola; Eugenio de Miguel; Naomi Schlesinger
Journal:  Arthritis Res Ther       Date:  2009-06-17       Impact factor: 5.156

10.  Cost-effectiveness of febuxostat in chronic gout.

Authors:  Stephen M Beard; Birgitta G von Scheele; George Nuki; Isobel V Pearson
Journal:  Eur J Health Econ       Date:  2013-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.